Serveur d'exploration sur la maladie de Parkinson - Exploration (Accueil)

Index « Keywords » - entrée « MPTP »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
MPP, 1-methyl 4-phenylpyridinium < MPTP < MPTP = N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine  Facettes :

List of bibliographic references indexed by MPTP

Number of relevant bibliographic references: 33.
[0-20] [0 - 20][0 - 33][20-32][20-40]
Ident.Authors (with country if any)Title
000265 (2011) James A. Miller [États-Unis] ; Briana R. Trout [États-Unis] ; Kelly A. Sullivan [États-Unis] ; Russell A. Bialecki [États-Unis] ; Ruth A. Roberts [Royaume-Uni] ; Ronald B. Tjalkens [États-Unis]Low‐dose 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine causes inflammatory activation of astrocytes in nuclear factor‐κB reporter mice prior to loss of dopaminergic neurons
000582 (2010) Kayhan A. Tayarani-Binazir [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Sarah Rose [Royaume-Uni] ; C. Warren Olanow [États-Unis] ; Peter Jenner [Royaume-Uni]Pramipexole combined with levodopa improves motor function but reduces dyskinesia in MPTP‐treated common marmosets
000603 (2010) Louisa Clare Johnston [Royaume-Uni] ; Michael John Jackson [Royaume-Uni] ; Sarah Rose [Royaume-Uni] ; Andrew Christopher Mccreary [Pays-Bas] ; Peter Jenner [Royaume-Uni]Pardoprunox reverses motor deficits but induces only mild dyskinesia in MPTP‐treated common marmosets
000A22 (2009) Shin-Ichi Muramatsu [Japon] ; Tsuyoshi Okuno [Japon] ; Yutaka Suzuki [Japon] ; Takashi Nakayama [Japon] ; Takeharu Kakiuchi [Japon] ; Naomi Takino [Japon] ; Asako Iida [Japon] ; Fumiko Ono [Japon] ; Keiji Terao [Japon] ; Nobuo Inoue [Japon] ; Imaharu Nakano [Japon] ; Yasushi Kondo [Japon] ; Hideo Tsukada [Japon]Multitracer assessment of dopamine function after transplantation of embryonic stem cell‐derived neural stem cells in a primate model of Parkinson's disease
000C93 (2008) Madeleine Diedrich [Allemagne] ; Lei Mao [Allemagne] ; Christian Bernreuther [Allemagne] ; Claus Zabel [Allemagne] ; Grit Nebrich [Allemagne] ; Ralf Kleene [Allemagne] ; Joachim Klose [Allemagne]Proteome analysis of ventral midbrain in MPTP‐treated normal and L1cam transgenic mice
000C98 (2008) Peter Jenner [Royaume-Uni]Preventing and controlling dyskinesia in Parkinson's disease—A view of current knowledge and future opportunities
000D51 (2008) Riccardo Ruffoli [Italie] ; Paola Soldani [Italie] ; Livia Pasquali [Italie] ; Stefano Ruggieri [Italie] ; Antonio Paparelli [Italie] ; Francesco Fornai [Italie]Methamphetamine Fails to Alter the Noradrenergic Integrity of the Heart
000D87 (2008) Patrick L. Mcgeer [Canada] ; Edith G. Mcgeer [Canada]Glial reactions in Parkinson's disease
000F26 (2007) Risa Sakai [Japon] ; Yoshifumi Irie [Japon] ; Takeshi Murata [Japon] ; Atsushi Ishige [Japon] ; Naoko Anjiki [Japon] ; Kenji Watanabe [Japon]Toki‐to protects dopaminergic neurons in the substantia nigra from neurotoxicity of MPTP in mice
000F72 (2007) Timothy M. Fountaine [Royaume-Uni] ; Richard Wade-Martins [Royaume-Uni]RNA interference‐mediated knockdown of α‐synuclein protects human dopaminergic neuroblastoma cells from MPP+ toxicity and reduces dopamine transport
001219 (2006) Patrick Mclaughlin [États-Unis] ; Yong Zhou [États-Unis] ; Tracy Ma [États-Unis] ; Jun Liu [États-Unis] ; Wei Zhang [États-Unis] ; Jau-Shyong Hong [États-Unis] ; Monika Kovacs [États-Unis] ; Jing Zhang [États-Unis]Proteomic analysis of microglial contribution to mouse strain–dependent dopaminergic neurotoxicity
001223 (2006) Marc Morissette [Canada] ; Mehdi Dridi [Canada] ; Frédéric Calon [Canada] ; Abdallah Hadj Tahar [Canada] ; Leonard T. Meltzer [États-Unis] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada]Prevention of levodopa‐induced dyskinesias by a selective NR1A/2B N‐methyl‐D‐aspartate receptor antagonist in parkinsonian monkeys: Implication of preproenkephalin
001254 (2006) David W. Anderson [États-Unis] ; Kristin A. Bradbury [États-Unis] ; Jay S. Schneider [États-Unis]Neuroprotection in Parkinson models varies with toxin administration protocol
001350 (2006) Gloria E. Meredith [États-Unis] ; Un Jung Kang [États-Unis]Behavioral models of Parkinson's disease in rodents: A new look at an old problem
001462 (2005) Lance A. Smith [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Ghassan Al-Barghouthy [Royaume-Uni] ; Sarah Rose [Royaume-Uni] ; Mikko Kuoppamaki [Royaume-Uni, États-Unis] ; Warren Olanow [Finlande] ; Peter Jenner [Royaume-Uni]Multiple small doses of levodopa plus entacapone produce continuous dopaminergic stimulation and reduce dyskinesia induction in MPTP‐treated drug‐naïve primates
001490 (2005) Silvia Mandel [Israël] ; Edna Grunblatt [Allemagne] ; Peter Riederer [Allemagne] ; Ninette Amariglio [Israël] ; Jasmine Jacob Hirsch [Israël] ; Gideon Rechavi [Israël] ; Moussa B. H. Youdim [Israël]Gene Expression Profiling of Sporadic Parkinson's Disease Substantia Nigra Pars Compacta Reveals Impairment of Ubiquitin‐Proteasome Subunits, SKP1A, Aldehyde Dehydrogenase, and Chaperone HSC‐70
001545 (2005) Mahmoud M. Iravani [Royaume-Uni] ; Emilie Syed [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Louisa C. Johnston [Royaume-Uni] ; Lance A. Smith [Royaume-Uni] ; Peter Jenner [Royaume-Uni]A modified MPTP treatment regime produces reproducible partial nigrostriatal lesions in common marmosets
001726 (2003) Peter Teismann [États-Unis] ; Kim Tieu [États-Unis] ; Oren Cohen [États-Unis] ; Dong-Kug Choi [États-Unis] ; Du Chu Wu [États-Unis] ; Daniel Marks [États-Unis] ; Miquel Vila [États-Unis] ; Vernice Jackson-Lewis [États-Unis] ; Serge Przedborski [États-Unis]Pathogenic role of glial cells in Parkinson's disease
001778 (2003) Lance A. Smith [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Matthew J. Hansard [Royaume-Uni] ; Eleni Maratos [Royaume-Uni] ; Peter Jenner [Royaume-Uni]Effect of pulsatile administration of levodopa on dyskinesia induction in drug‐naïve MPTP‐treated common marmosets: Effect of dose, frequency of administration, and brain exposure
001857 (2002) Hagai Bergman [Israël] ; Günther Deuschl [Allemagne]Pathophysiology of Parkinson's disease: From clinical neurology to basic neuroscience and back
001A17 (2001) Diana Frechilla [Espagne] ; Almudena Cobreros [Espagne] ; Laura Saldise [Espagne] ; Rosario Moratalla [Espagne] ; Ricardo Insausti [Espagne] ; M-Rosario Luquin [Espagne] ; Joaquín Del Río [Espagne]Serotonin 5‐HT1A receptor expression is selectively enhanced in the striosomal compartment of chronic parkinsonian monkeys

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "MPTP" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "MPTP" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    MPTP
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024